SAMSRITA LABS LIMITED (SAMSRITA.BO)
INR 22.97
(4.98%)
INR 22.97
(4.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 155.51 Million INR | -0.07% |
| 2022 | 155.62 Million INR | -9.14% |
| 2021 | 171.28 Million INR | 3.33% |
| 2020 | 165.76 Million INR | -41.24% |
| 2019 | 282.12 Million INR | 7.58% |
| 2018 | 262.23 Million INR | 14.5% |
| 2017 | 229.02 Million INR | 18.97% |
| 2016 | 192.49 Million INR | 247.16% |
| 2015 | 55.44 Million INR | -12.41% |
| 2014 | 63.3 Million INR | 49.26% |
| 2013 | 42.41 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 155.51 Million INR | 0.0% |
| 2023 FY | 155.51 Million INR | -0.07% |
| 2023 Q2 | 156.34 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 172.64 Million INR | 0.0% |
| 2022 Q4 | 155.62 Million INR | 0.0% |
| 2022 FY | 155.62 Million INR | -9.14% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 171.28 Million INR | 3.33% |
| 2021 Q4 | 171.28 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 286.88 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 165.76 Million INR | -41.24% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 284.17 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 286.5 Million INR | 0.0% |
| 2019 Q2 | 278.95 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 282.12 Million INR | 7.58% |
| 2019 Q1 | - INR | 0.0% |
| 2019 Q4 | 282.12 Million INR | 0.0% |
| 2018 FY | 262.23 Million INR | 14.5% |
| 2017 FY | 229.02 Million INR | 18.97% |
| 2016 Q2 | 37.46 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 192.82 Million INR | 0.0% |
| 2016 FY | 192.49 Million INR | 247.16% |
| 2015 FY | 55.44 Million INR | -12.41% |
| 2014 FY | 63.3 Million INR | 49.26% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q4 | 63.3 Million INR | 0.0% |
| 2013 FY | 42.41 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.78 Billion INR | 91.291% |
| Biocon Limited | 560.7 Billion INR | 99.972% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | 98.531% |
| Concord Biotech Limited | 17 Billion INR | 99.086% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 99.838% |
| FERMENTA BIOTECH LIMITED | 5.47 Billion INR | 97.161% |
| GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -258.848% |
| Lyka Labs Limited | 1.56 Billion INR | 90.077% |
| Panacea Biotec Limited | 12.4 Billion INR | 98.747% |
| Servoteach Industries Limited | 1591.00 INR | -9774444.312% |
| SMS Lifesciences India Limited | 3.9 Billion INR | 96.018% |
| Supriya Lifescience Limited | 9.21 Billion INR | 98.312% |
| Syngene International Limited | 61.51 Billion INR | 99.747% |
| TAKE Solutions Limited | 881.05 Million INR | 82.349% |
| Titan Biotech Limited | 1.56 Billion INR | 90.068% |
| Transgene Biotek Limited | 324.4 Million INR | 52.062% |
| Vanta Bioscience Limited | 853.96 Million INR | 81.789% |